A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
VA Office of Research and Development
Fox Chase Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
NYU Langone Health